top of page

The Lee Lab's publications

We are proud of our  achievements

Featured Publications

Tracking Antigen-Specific TCR Clonotypes in SARS-CoV-2 Infection Reveals Distinct Severity Trajectories ​

Journal of Medical Virology (IF: 12.7)

Broad humoral and cellular immunity elicited by one dose mRNA vaccination 18 months after SARS-CoV-2 infection

BMC Medicine (IF: 11.806)

Engineering of a human kringle domain into agonistic and antagonistic binding proteins functioning in vitro and in vivo.​

PNAS

(IF=12.779)

Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted individuals ​

Journal of Medical Virology (IF: 20.693)

Will ETA Antibodies Arouse New Interest in Cancer Therapeutics?​

Trends in Pharmacological Sciences (IF:17.638)

IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector function.

Nature Immunology

(IF: 31.250)

 2023

34

Chang Kyung Kang#, Youngju Kim#, Hyeon Jae Jo, Chan Mi Lee, Nam Joong Kim, Chang-Han Lee, Pyoeng Gyun Choe*, Wan Beom Park*, Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Positivity of anti-SARS-CoV-2 nucleocapsid antibody 3 years post COVID-19

 

Submitted

33

Chan Mi Lee#, Minji Kim#, Seong-wook Park#, Chang Kyung Kang#, Pyoeng Gyun Choe, Nam Joong Kim, Hyun Mu Shin, Chang-Han Lee*, Hyun Mu Shin*, Hang-Rae Kim*, Wan Beom Park*, and Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Clinical outcomes and immunological features of COVID-19 in patients receiving B-cell depleting therapy during the Omicron era

 

Infectious Diseases (IF: 5.8), 02 Nov 2023, https://doi.org/10.1080/23744235.2023.2276784

32

IK Soo Kim#, Chang Kyung Kang#, Seung Jae Lee#, Chang-Han Lee#, Minji Kim, Chaehwa Seo, Gwanghun Kim, Soojin Lee, Kyoung Sun Park, Euijin Chang, Jongtak Jung, Kyoung-Ho Song, Pyoeng Gyun Choe, Wan Beom Park, Eu Suk Kim, Hong Bin Kim, Nam Joong Kim, Myoung-don Oh, Jong-Eun Lee, Hang-Rae Kim, Hyun Mu Shin*, and Hang-Rae Kim*

# Co-first author, *Co-corresponding author

​

Tracking Antigen-Specific TCR Clonotypes in SARS-CoV-2 Infection Reveals Distinct Severity Trajectories

 

Journal of Medical Virology (IF: 12.7), 02 November 2023, https://doi.org/10.1002/jmv.29199

​

한빛사 소개

https://www.ibric.org/bric/hanbitsa/treatise.do?mode=treatise-view&id=91343&authorId=10006&pager.offset=0&pagerLimit=10&srAuthorId=10006&beforemode=author-treatise-list#!/list

31

Chan Mi Lee#, Pyoeng Gyun Choe#, Chang Kyung Kang#, Eunyoung Lee, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Nam Joong Kim, Hang-Rae Kim, Youngju Kim, Chang-Han Lee, Hyun Mu Shin*, Sang-Won Park*, Wan Beom Park*, and Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Low humoral and cellular immune responses early fater breakthrough infection may contribute to severe COVID-19

 

Frontiers in Immunology (IF: 8.787), doi.org/10.3389/fimmu.2023.1106664

30

Chang Kyung Kang#, Min-Gang Kim#, Seong-wook Park#, Yong-Woo Kim, Chan Mi Lee, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Minji Kim, Soojin Lee, Ik Soo Kim, Chang-Han Lee*, Hyun Mu Shin*, Hang-Rae Kim*, Myoung-don Oh*

# Co-first author, *Co-corresponding author

​

Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted individuals 

​

Journal of Medical Virology (IF: 20.693), doi: 10.1002/jmv.28558, Feb 8 (2023)

​

한빛사 소개

https://www.ibric.org/myboard/read.php?Board=HBS_TREATISE&id=83636&idauthorid=10006&ttype=

 2022

29

Chanho Kong#, Eun-Jeong Yang#, Jaewoo Shin#, Junwon Park, Si-Hyun Kim, Seong-Wook Park, Won Seok Chang, Chang-Han Lee, Hyunju Kim*, Hye-Sun Kim*, Jin Woo Chang*

# Co-first author, *Co-corresponding author

​

Enhanced delivery of low-dose of aducanumab via FUS in 5xFAD mice, an AD model

​

Translational Neurodegeneration (IF: 9.883), 11, Article number: 57 (2022) 

28

Yong-Jin Kwon, Eun-Bi Seo, Ae Jin Jeong, Song-Hee Lee, Kum Hee Noh, Sangsik Lee, Chung-Hyun Cho, Chang-Han Lee, Hyun Mu Shin, Hang-Rae Kim, Hyeong-Gon Moon & Sang-Kyu Ye

​

The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells

​

BMC Cancer (IF:4.638),  22, Article number: 852 (2022)

27

Jinyong Kim#, Jiyun Jeong#, Chan Mi Lee, Dae-Won Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Myoung-don Oh, Chang-Han Lee, Wan Beom Park*, Kyung-Hun Lee*, and Seock-Ah Im

# Co-first author, *Co-corresponding author

​

Prospective Longitudinal Analysis of Antibody Response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

​

Frontiers in Immunology (IF: 8.787), 17 November 2022, https://doi.org/10.3389/fimmu.2022.1028102

26

Chang Kyung Kang#, Hyun Mu Shin#, Pyoeng Gyun Choe#, Jiyoung Park,  Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee*, Jun-Young Seo*, Wan Beom Park*, Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Broad humoral and cellular immunity elicited by one dose mRNA vaccination 18 months after SARS-CoV-2 infection

​

BMC Medicine (IF: 11.806), 20, 181 (2022). https://doi.org/10.1186/s12916-022-02383-4

​

서울대 홈페이지 소개

https://www.snu.ac.kr/coronavirus

​

한빛사 소개

https://www.ibric.org/myboard/read.php?Board=hbs_treatise&id=76052&idauthorid=10006&ttype=0

​

언론보도

https://www.ytn.co.kr/_ln/0103_202205061129398843

https://www.mk.co.kr/news/it/view/2022/05/401385/

http://www.healthinnews.co.kr/news/articleView.html?idxno=29792

25

Pyoeng Gyun Choe#, Jisu Hong#, Jiyoung Park, Euijin Chang, Chang Kyung Kang, Nam Joong Kim, Chang-Han Lee*, Wan Beom Park*, and Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection

​

Journal of Infectious Diseases (IF: 7.759), 17 March 2022

24

Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee,  Hyun Mu Shin, Chang-Han Lee*, Wan Beom Park*, Hang-Rae Kim* and Myoung-don Oh

# Co-first author, *Co-corresponding author

​

Distinctive immune response after one-year post COVID-19 according to the severity

​

Frontiers in Immunology (IF: 8.787), 21 March 2022, vol 13, 830433

23

Han-Seok Jeong, Da-Hye Lee, Seung-Hoon Kim, Chang-Han Lee, Hyun Mu Shin, Hang-Rae Kim, Chung-Hyun Cho*

​

Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1

​

Oncogene (IF: 8.756), January 29, 2022

 2021

22

Jiyoung Park and Chang-Han Lee*

​

Will ETA Antibodies Arouse New Interest in Cancer Therapeutics?

​

Trends in Pharmacological Sciences (IF:17.638), December 09, 2021

​

한빛사 소개

https://www.ibric.org/myboard/read.php?Board=HBS_TREATISE&id=73462&idauthorid=36696&ttype=

21

Chang‐Han Lee and George Delidakis

​

Chapter 13. Engineering IgG1 Fc domains that activate the complement system

​

Methods in Molecular Biology - Immune Receptors (MIMB, volume 2421) pp 187-200 December 7 2021; 8 (5)

20

Jie Li, Sam A Bazzi, Florian Schmitz, Hidetaka Tanno, Jonathan R McDaniel, Chang-Han Lee, Chaitanya Joshi, Jin Eyun Kim, Nancy Monson, Benjamin M Greenberg, Kristina Hedfalk, Esther Melamed, and Gregory C Ippolito

 

Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder

​

Neurol Neuroimmunol Neuroinflamm (IF: 11.360), September 2021; 8 (5)

19

Seung Hyun Kang and Chang‐Han Lee* 

​

Development of therapeutic antibodies and modulating the characteristics of therapeutic antibodies to maximize the therapeutic efficacy

​

Biotechnology and Bioprocess Engineering (IF:3.386), 2021, June 28

18

Chang Kyung Kang*, Minji Kim*, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Chang‐Han Lee, Ik Soo Kim, Keehoon Jung, Dong-Sup Lee,  Hyun Mu Shin, Hang-Rae Kim*, and Myoung-don Oh*

 

Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection

​

Journal of Infectious Diseases (IF: 7.759), 2021, Mar 23

bottom of page